Article
Fish Attorneys Author Fourth Article of a Four-Part Series in Biosimilar Development, "Biosimilar Litigation Review: Anticompetitive Conduct Cases & Post-Grant Patent Challenges"
Authors
-
- Name
- Person title
- Associate
The final article of a four-part series on 2019 legal developments related to the biosimilar sector is now available. Written by Fish principal Jenny Shmuel and associates Philip Chen and Felix Eyzaguirre, this article focuses on 2019 biosimilar litigation related to anticompetitive conduct and post-grant patent challenges at the Patent Trial and Appeal Board (PTAB), and looks to what biosimilar developers can anticipate throughout 2020.
Authors: Philip Chen, Felix Eyzaguirre, Tasha Francis, Jenny Shmuel
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.